Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Anbio Biotechnology Class A Ordinary Shares, Common Stock

NNNN

NASDAQ

$5.77

+$0.1

(1.76%)

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$253.25M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

140.73K

Avg Volume

This is the average number of shares traded during the most recent 30 days.

Dividend Yield

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$5.18 L

$5.89 H

$5.77

About Anbio Biotechnology Class A Ordinary Shares, Common Stock

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany. more

Returns

Data is not properly formatted.

Time Frame	NNNN		S&P500
1-Week Return	-1.73%%	%	0.11%%

Financials

	Dec '21	Dec '22	Dec '23
Total Revenue	4.43M	23.54M	6.71M	[{"date":"2021-12-31","value":18.81,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":28.51,"profit":true}]
Cost of Revenue	1.89M	10.98M	3.35M	[{"date":"2021-12-31","value":17.18,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":30.52,"profit":true}]
Gross Profit	2.54M	12.56M	3.36M	[{"date":"2021-12-31","value":20.23,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":26.75,"profit":true}]
Gross Margin	57.40%	53.36%	50.07%	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":92.96,"profit":true},{"date":"2023-12-31","value":87.23,"profit":true}]

Operating Expenses	1.97M	13.35M	4.75M	[{"date":"2021-12-31","value":14.78,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":35.59,"profit":true}]
Operating Income	2.46M	10.20M	1.96M	[{"date":"2021-12-31","value":24.09,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":19.23,"profit":true}]
Total Non-Operating Income/Expense	79.94K	(184.41K)	292.78K	[{"date":"2021-12-31","value":27.3,"profit":true},{"date":"2022-12-31","value":-62.99,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income	2.54M	10.01M	2.25M	[{"date":"2021-12-31","value":25.33,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":22.51,"profit":true}]
Income Taxes	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	2.54M	10.01M	2.25M	[{"date":"2021-12-31","value":25.33,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":22.51,"profit":true}]
Income From Discontinued Operations	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	2.54M	10.01M	2.25M	[{"date":"2021-12-31","value":25.33,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":22.51,"profit":true}]

EPS (Diluted)	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

	Dec '21	Dec '22	Dec '23
Total Revenue	-	431.67%	(71.49%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-16.56,"profit":false}]
Cost of Revenue	-	482.08%	(69.48%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-14.41,"profit":false}]
Gross Profit	-	394.25%	(73.25%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-18.58,"profit":false}]
Gross Margin	-	(7.04%)	(6.16%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Operating Expenses	-	576.73%	(64.41%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-11.17,"profit":false}]
Operating Income	-	315.15%	(80.77%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-25.63,"profit":false}]
Total Non-Operating Income/Expense	-	(330.70%)	(258.76%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Pre-Tax Income	-	294.79%	(77.49%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-26.29,"profit":false}]
Income Taxes	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	294.79%	(77.49%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-26.29,"profit":false}]
Income From Discontinued Operations	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	294.79%	(77.49%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-26.29,"profit":false}]

EPS (Diluted)	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]

	Dec '21	Dec '22	Dec '23
Total Assets
Current Assets	4.92M	13.94M	15.75M	[{"date":"2021-12-31","value":31.21,"profit":true},{"date":"2022-12-31","value":88.53,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Assets	-	15.05K	62.14K	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":24.22,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Assets	4.92M	13.96M	15.81M	[{"date":"2021-12-31","value":31.09,"profit":true},{"date":"2022-12-31","value":88.28,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	2.38M	1.41M	993.06K	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":59.3,"profit":true},{"date":"2023-12-31","value":41.73,"profit":true}]
Non-current Liabilities	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Liabilities	2.38M	1.41M	993.06K	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":59.3,"profit":true},{"date":"2023-12-31","value":41.73,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	2.54M	12.55M	14.80M	[{"date":"2021-12-31","value":17.13,"profit":true},{"date":"2022-12-31","value":84.77,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Shareholders' equity	2.54M	12.55M	14.82M	[{"date":"2021-12-31","value":17.11,"profit":true},{"date":"2022-12-31","value":84.67,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	4.92M	13.96M	15.81M	[{"date":"2021-12-31","value":31.09,"profit":true},{"date":"2022-12-31","value":88.28,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '21	Dec '22	Dec '23
Total Assets
Current Assets	-	183.65%	12.96%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":7.05,"profit":true}]
Non-current Assets	-	-	312.93%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Assets	-	183.95%	13.28%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":7.22,"profit":true}]

Total Liabilities
Current Liabilities	-	(40.70%)	(29.63%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Non-current Liabilities	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Liabilities	-	(40.70%)	(29.63%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	-	394.79%	17.96%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":4.55,"profit":true}]
Other Stockholders' Equity	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	394.79%	18.11%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":4.59,"profit":true}]

Total Liabilities & Shareholders Equity	-	183.95%	13.28%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":7.22,"profit":true}]

	Jun '23	Dec '23	Jun '24
Total Assets
Current Assets	15.15M	15.75M	18.77M	[{"date":"2023-06-30","value":80.72,"profit":true},{"date":"2023-12-31","value":83.93,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Non-current Assets	280.07K	62.14K	176.99K	[{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-12-31","value":22.19,"profit":true},{"date":"2024-06-30","value":63.2,"profit":true}]
Total Assets	15.43M	15.81M	18.94M	[{"date":"2023-06-30","value":81.44,"profit":true},{"date":"2023-12-31","value":83.47,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	1.34M	993.06K	527.75K	[{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-12-31","value":74.02,"profit":true},{"date":"2024-06-30","value":39.33,"profit":true}]
Non-current Liabilities	-	-	-	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Total Liabilities	1.34M	993.06K	527.75K	[{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-12-31","value":74.02,"profit":true},{"date":"2024-06-30","value":39.33,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Retained Earnings	14.07M	14.80M	18.40M	[{"date":"2023-06-30","value":76.47,"profit":true},{"date":"2023-12-31","value":80.45,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Other Stockholders' Equity	-	-	-	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Total Shareholders' equity	14.09M	14.82M	18.42M	[{"date":"2023-06-30","value":76.49,"profit":true},{"date":"2023-12-31","value":80.47,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	15.43M	15.81M	18.94M	[{"date":"2023-06-30","value":81.44,"profit":true},{"date":"2023-12-31","value":83.47,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]

	Jun '23	Dec '23	Jun '24
Total Assets
Current Assets	-	3.98%	19.15%	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":20.76,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Non-current Assets	-	(77.81%)	184.84%	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":-42.1,"profit":false},{"date":"2024-06-30","value":100,"profit":true}]
Total Assets	-	2.49%	19.80%	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":12.58,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	(25.98%)	(46.86%)	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-06-30","value":null,"profit":false}]
Non-current Liabilities	-	-	-	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Total Liabilities	-	(25.98%)	(46.86%)	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-06-30","value":null,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Retained Earnings	-	5.21%	24.30%	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":21.44,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Other Stockholders' Equity	-	-	-	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Total Shareholders' equity	-	5.20%	24.27%	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":21.44,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	2.49%	19.80%	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":12.58,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]

	Dec '21	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	4.18M	4.45M	898.37K	[{"date":"2021-12-31","value":93.99,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":20.19,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	-	(42.84K)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Net Change in Cash	4.18M	2.92M	2.59M	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":69.86,"profit":true},{"date":"2023-12-31","value":61.84,"profit":true}]

Free Cash Flow
Free Cash Flow	4.18M	4.45M	898.37K	[{"date":"2021-12-31","value":93.99,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":20.19,"profit":true}]

	Dec '21	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	-	6.40%	(79.81%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1247.37,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Net Change in Cash	-	(30.14%)	(11.48%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	6.40%	(79.81%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1247.37,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	NNNN
Current Ratio	35.56

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	NNNN
ROA (LTM)	0.00%
ROE (LTM)	0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	NNNN
Debt Ratio Lower is generally better. Negative is bad.	0.03
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.97

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	NNNN
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	0.00
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Anbio Biotechnology Class A Ordinary Shares share price today?

Anbio Biotechnology Class A Ordinary Shares (NNNN) share price today is $5.77

Can Indians buy Anbio Biotechnology Class A Ordinary Shares shares?

Yes, Indians can buy shares of Anbio Biotechnology Class A Ordinary Shares (NNNN) on Vested. To buy Anbio Biotechnology Class A Ordinary Shares from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NNNN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Anbio Biotechnology Class A Ordinary Shares be purchased?

Yes, you can purchase fractional shares of Anbio Biotechnology Class A Ordinary Shares (NNNN) via the Vested app. You can start investing in Anbio Biotechnology Class A Ordinary Shares (NNNN) with a minimum investment of $1.

How to invest in Anbio Biotechnology Class A Ordinary Shares shares from India?

You can invest in shares of Anbio Biotechnology Class A Ordinary Shares (NNNN) via Vested in three simple steps:

Click on Sign Up or Invest in NNNN stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Anbio Biotechnology Class A Ordinary Shares shares

What is Anbio Biotechnology Class A Ordinary Shares 52-week high and low stock price?

The 52-week high price of Anbio Biotechnology Class A Ordinary Shares (NNNN) is $5.89. The 52-week low price of Anbio Biotechnology Class A Ordinary Shares (NNNN) is $5.18.

What is Anbio Biotechnology Class A Ordinary Shares price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Anbio Biotechnology Class A Ordinary Shares (NNNN) is 0.00

What is the Market Cap of Anbio Biotechnology Class A Ordinary Shares?

The market capitalization of Anbio Biotechnology Class A Ordinary Shares (NNNN) is $253.25M

What is Anbio Biotechnology Class A Ordinary Shares’s stock symbol?

The stock symbol (or ticker) of Anbio Biotechnology Class A Ordinary Shares is NNNN